Episurf Medical reaches milestone of 1,000 implants
Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by the planning of the 1,000th surgery with the Episealer® implant. Over 450 patients have had the implant for more than 2 years, and approximately 80 patients have passed 5 years since surgery. The majority are knee patients (Episealer® Knee), but the company is also executing on its early commercialization of the ankle implant, Episealer® Talus. ”I am very proud of the Episurf team today, and I would like to congratulate Prof. Ryd on this great achievement. Our history of strong clinical